Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Nihar R. Desai
Based on 7 articles published since 2009
(Why 7 articles?)
||||
Expertise Level
The expertise of Nihar R. Desai ranks in the
  • Top 0.18%
  • ... of 27,392 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Yale University   Contact    
2018
  • Tecnologico de Monterrey, Catedra de Cardiología y Medicina Vascular, Nuevo Leon, Mexico; Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA. · Division of Cardiac Surgery, University of British Columbia, Vancouver, BC, Canada. · Center for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale University, New Haven, CT, USA. · Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA. · Division of Cardiology and Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. · Division of Cardiology, UT Southwestern Medical Center, Dallas, TX, USA. · Michael E. DeBakey VA Medical Center & Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA. · Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Boston, MA, USA. · The Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD, USA. · Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA; The Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD, USA; Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA; Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA; Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, USA. Electronic address: · Pubmed 29254694
2017
  • Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale-New Haven Health Services Corporation, New Haven, Connecticut. · Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California5currently with AbbVie Inc, North Chicago, Illinois. · Pubmed 28122070
2015
  • Section of Cardiovascular Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT. · TIMI study Group, Division of Cardiovascular Medicine, Brigham and Women׳s Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25771732
Probable:    Harvard University Boston   Contact    
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Nihar R. Desai in 2009-2019 about Hypercholesterolemia:

  • Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. 2018
  • Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab. 2017
  • PCSK9 inhibition in patients with hypercholesterolemia. 2015
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. 2013
  • Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study. 2012
  • Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy. 2012
Show List of Full Article Records
Google Searches

Learn more about Nihar R. Desai using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Yale University
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Yale University
2018
  • Tecnologico de Monterrey, Catedra de Cardiología y Medicina Vascular, Nuevo Leon, Mexico; Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA. · Division of Cardiac Surgery, University of British Columbia, Vancouver, BC, Canada. · Center for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale University, New Haven, CT, USA. · Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA. · Division of Cardiology and Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. · Division of Cardiology, UT Southwestern Medical Center, Dallas, TX, USA. · Michael E. DeBakey VA Medical Center & Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA. · Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Radiology, Brigham and Women's Hospital, Boston, MA, USA. · The Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD, USA. · Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, FL, USA; The Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD, USA; Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA; Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA; Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, USA. Electronic address: · Pubmed 29254694
2017
  • Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale-New Haven Health Services Corporation, New Haven, Connecticut. · Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California5currently with AbbVie Inc, North Chicago, Illinois. · Pubmed 28122070
2015
  • Section of Cardiovascular Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT. · TIMI study Group, Division of Cardiovascular Medicine, Brigham and Women׳s Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25771732
Harvard University Boston
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
Yearly article counts 01101112000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.